72 related articles for article (PubMed ID: 27939881)
1. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63.
Ogata T; Nakamura M; Sang M; Yoda H; Hiraoka K; Yin D; Sang M; Shimozato O; Ozaki T
PLoS One; 2017; 12(7):e0179884. PubMed ID: 28671946
[TBL] [Abstract][Full Text] [Related]
2. Reconciling ASPP-p53 binding mode discrepancies through an ensemble binding framework that bridges crystallography and NMR data.
Liu T; Huang S; Zhang Q; Xia Y; Zhang M; Sun B
PLoS Comput Biol; 2024 Feb; 20(2):e1011519. PubMed ID: 38324587
[TBL] [Abstract][Full Text] [Related]
3. TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities.
Huo Y; Cao K; Kou B; Chai M; Dou S; Chen D; Shi Y; Liu X
Genes Dis; 2023 Sep; 10(5):1982-1993. PubMed ID: 37492707
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
[TBL] [Abstract][Full Text] [Related]
5. ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.
Rieger I; Tsintari V; Overkamp M; Fend F; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
Front Mol Biosci; 2021; 8():727203. PubMed ID: 34805267
[TBL] [Abstract][Full Text] [Related]
6. Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2.
Wu T; Song H; Xie D; Hua K; Hu J; Deng Y; Ji C; Fang L
Biomed Res Int; 2020; 2020():7907269. PubMed ID: 32420372
[TBL] [Abstract][Full Text] [Related]
7. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
Schipper K; Drenth AP; van der Burg E; Cornelissen S; Klarenbeek S; Nethe M; Jonkers J
Cancer Res; 2020 Apr; 80(7):1486-1497. PubMed ID: 32060147
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
9. Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.
Pfeifer A; Rusinek D; Żebracka-Gala J; Czarniecka A; Chmielik E; Zembala-Nożyńska E; Wojtaś B; Gielniewski B; Szpak-Ulczok S; Oczko-Wojciechowska M; Krajewska J; Polańska J; Jarząb B
Genes Chromosomes Cancer; 2019 Aug; 58(8):558-566. PubMed ID: 30664823
[TBL] [Abstract][Full Text] [Related]
10. Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Kas SM; de Ruiter JR; Schipper K; Annunziato S; Schut E; Klarenbeek S; Drenth AP; van der Burg E; Klijn C; Ten Hoeve JJ; Adams DJ; Koudijs MJ; Wesseling J; Nethe M; Wessels LFA; Jonkers J
Nat Genet; 2017 Aug; 49(8):1219-1230. PubMed ID: 28650484
[TBL] [Abstract][Full Text] [Related]
11. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
12. New insights into the expanding complexity of the tumor suppressor ASPP2.
Kampa KM; Bonin M; Lopez CD
Cell Cycle; 2009 Sep; 8(18):2871-6. PubMed ID: 19657229
[TBL] [Abstract][Full Text] [Related]
13. ASPP2: a gene that controls life and death in vivo.
Vives V; Slee EA; Lu X
Cell Cycle; 2006 Oct; 5(19):2187-90. PubMed ID: 16969108
[TBL] [Abstract][Full Text] [Related]
14. ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.
Van Hook K; Wang Z; Chen D; Nold C; Zhu Z; Anur P; Lee HJ; Yu Z; Sheppard B; Dai MS; Sears R; Spellman P; Lopez CD
Biochem Biophys Res Commun; 2017 Jan; 482(4):1271-1277. PubMed ID: 27939881
[TBL] [Abstract][Full Text] [Related]
15. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
16. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
